Stina Syvänen
Professor at Department of Public Health and Caring Sciences; Molecular Geriatrics / Rudbeck laboratory
- Telephone:
- +46 18 471 34 05
- Mobile phone:
- +46 73 469 74 52
- E-mail:
- stina.syvanen@uu.se
- Visiting address:
- Dag Hammarskjölds väg 20
- Postal address:
- Rudbecklaboratoriet
751 85 Uppsala
Professor Deputy head of department at Department of Public Health and Caring Sciences; Administration
- Mobile phone:
- +46 73 469 74 52
- E-mail:
- stina.syvanen@uu.se
- Visiting address:
- BMC, Husargatan 3
- Postal address:
- Box 564
751 22 UPPSALA
Biography
ACADEMIC EDUCATION AND PROFESSIONAL EXPERIENCE
2021-present: Professor and Head of research group Molecular Geriatrics, Department of Public Health and Caring Sciences, Faculty of Medicine, Uppsala University.
2012-2020: Researcher/Assoc Prof, Molecular Geriatrics, Department of Public Health and Caring Sciences, Faculty of Medicine, Uppsala University
2008-2012: Postdoctoral researcher, Division of Pharmacology, Leiden University, The Netherlands.
2006-2007: Visiting scientist at the Neurobiology Research Unit, Copenhagen University. Hospital (Rigshospitalet), Denmark (5 months)
2003-2008: PhD, Department of Pharmaceutical Biosciences, Faculty of Pharmacy, Uppsala University
1997-2003: Master of Science in Chemical Engineering, Uppsala University
1999-2000: One academic year at University of Edinburgh, UK. ERASMUS scholarship.
COMISSION OF TRUST
2025-present: Panel Chair (MH-11) of the Swedish Research Council
2023-present: Member of SciLifeLab committee, Uppsala University
2020-present: Member of the scientific advisory board Swedish Alzheimer Foundation
ACADEMIC HONOR
2023: Eric K Fernström price to a young, especially promising researcher, within medical research
2017: Queen Silvia’s research award to a young researcher within the field of Alzheimer’s disease handed out by Alzheimerfonden
2016: Fondkistan’s research award to young researchers
Research
Our research is focused on understanding the molecular mechanisms behind Alzheimer's disease and other types of dementia. We have generated antibodies that bind specifically to different forms of Aβ or α-synuclein, or other disease relevant proteins such as microglia protein TREM2. Some of the antibodies have also been modified to bind the transferrin receptor (TfR), which is normally involved in iron transport into the brain. The interaction with TfR works like a molecular Trojan horse, which transports the antibody into the brain, where it can bind to its target. This modification increases antibody brain concentration up to 100-fold. These bispecific antibodies have been explored as novel PET radioligands and as immunotherapeutics.
In parallel with the development of brain penetrant antibodies we study changes in the blood-brain barrier (BBB) during neurodegeneration. We also use small molecule PET radioligands to investigate pathology in the ageing brain focusing mainly on protein deposits, neuroinflammation and synaptic dysfunction.

Publications
Selection of publications
-
PET imaging of TREM2 in amyloid-beta induced neuroinflammation
Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 4320-4333, 2025
- DOI for PET imaging of TREM2 in amyloid-beta induced neuroinflammation
- Download full text (pdf) of PET imaging of TREM2 in amyloid-beta induced neuroinflammation
-
Part of Translational Neurodegeneration, 2025
- DOI for Pretargeted brain PET imaging reveals amyloid-β pathology using a TCO-modified antibody and a fluorine-18-labeled tetrazine
- Download full text (pdf) of Pretargeted brain PET imaging reveals amyloid-β pathology using a TCO-modified antibody and a fluorine-18-labeled tetrazine
-
Bispecific brain-penetrant antibodies for treatment of Alzheimer's disease
Part of The Journal of Prevention of Alzheimer's Disease, 2025
- DOI for Bispecific brain-penetrant antibodies for treatment of Alzheimer's disease
- Download full text (pdf) of Bispecific brain-penetrant antibodies for treatment of Alzheimer's disease
-
The effects of dose, valency, and affinity on TfR-mediated brain delivery in vivo
Part of Fluids and Barriers of the CNS, 2025
- DOI for The effects of dose, valency, and affinity on TfR-mediated brain delivery in vivo
- Download full text (pdf) of The effects of dose, valency, and affinity on TfR-mediated brain delivery in vivo
-
Age, dose, and binding to TfR on blood cells influence brain delivery of a TfR-transported antibody
Part of Fluids and Barriers of the CNS, 2023
- DOI for Age, dose, and binding to TfR on blood cells influence brain delivery of a TfR-transported antibody
- Download full text (pdf) of Age, dose, and binding to TfR on blood cells influence brain delivery of a TfR-transported antibody
-
Part of Fluids and Barriers of the CNS, 2022
- DOI for Brain pharmacokinetics of mono- and bispecific amyloid-beta antibodies in wild-type and Alzheimer's disease mice measured by high cut-off microdialysis
- Download full text (pdf) of Brain pharmacokinetics of mono- and bispecific amyloid-beta antibodies in wild-type and Alzheimer's disease mice measured by high cut-off microdialysis
-
Part of Journal of Nuclear Medicine, p. 302-309, 2022
- DOI for 11C-PiB and 124I-antibody PET provide differing estimates of brain amyloid-β after therapeutic intervention
- Download full text (pdf) of 11C-PiB and 124I-antibody PET provide differing estimates of brain amyloid-β after therapeutic intervention
-
Antibody-based PET imaging of amyloid beta in mouse models of Alzheimer's disease
Part of Nature Communications, 2016
- DOI for Antibody-based PET imaging of amyloid beta in mouse models of Alzheimer's disease
- Download full text (pdf) of Antibody-based PET imaging of amyloid beta in mouse models of Alzheimer's disease
-
Part of Drug Metabolism And Disposition, p. 635-643, 2009
-
On the rate and extent of drug delivery to the brain
Part of Pharmaceutical research, p. 1737-1750, 2008
Recent publications
-
Part of Journal of Nuclear Medicine, p. 463-470, 2026
- DOI for Radionuclide Selection Influences Imaging Outcomes in Immuno-PET with a Brain-Penetrating Anti–Amyloid-β Antibody
- Download full text (pdf) of Radionuclide Selection Influences Imaging Outcomes in Immuno-PET with a Brain-Penetrating Anti–Amyloid-β Antibody
-
Part of Nature Communications, 2026
- DOI for Heterogenous microglial reactivity contrasts with stable vascular transcriptional programs in mouse models of Alzheimer's, CADASIL, and Traumatic Brain Injury
- Download full text (pdf) of Heterogenous microglial reactivity contrasts with stable vascular transcriptional programs in mouse models of Alzheimer's, CADASIL, and Traumatic Brain Injury
-
Part of Neurotherapeutics, 2026
- DOI for Brain interstitial fluid pharmacokinetics and therapeutic effect of a BBB penetrating amyloid beta antibody measured by microdialysis
- Download full text (pdf) of Brain interstitial fluid pharmacokinetics and therapeutic effect of a BBB penetrating amyloid beta antibody measured by microdialysis
-
Part of Experimental Neurology, 2026
- DOI for Evaluating the impact of age and treatment on neuroinflammation-related proteins in mouse models of proteinopathies
- Download full text (pdf) of Evaluating the impact of age and treatment on neuroinflammation-related proteins in mouse models of proteinopathies
-
Part of Fluids and Barriers of the CNS, 2025
- DOI for High-affinity transferrin receptor binding improves brain delivery of bispecific antibodies at tracer dose
- Download full text (pdf) of High-affinity transferrin receptor binding improves brain delivery of bispecific antibodies at tracer dose
All publications
Articles in journal
-
Part of Journal of Nuclear Medicine, p. 463-470, 2026
- DOI for Radionuclide Selection Influences Imaging Outcomes in Immuno-PET with a Brain-Penetrating Anti–Amyloid-β Antibody
- Download full text (pdf) of Radionuclide Selection Influences Imaging Outcomes in Immuno-PET with a Brain-Penetrating Anti–Amyloid-β Antibody
-
Part of Nature Communications, 2026
- DOI for Heterogenous microglial reactivity contrasts with stable vascular transcriptional programs in mouse models of Alzheimer's, CADASIL, and Traumatic Brain Injury
- Download full text (pdf) of Heterogenous microglial reactivity contrasts with stable vascular transcriptional programs in mouse models of Alzheimer's, CADASIL, and Traumatic Brain Injury
-
Part of Neurotherapeutics, 2026
- DOI for Brain interstitial fluid pharmacokinetics and therapeutic effect of a BBB penetrating amyloid beta antibody measured by microdialysis
- Download full text (pdf) of Brain interstitial fluid pharmacokinetics and therapeutic effect of a BBB penetrating amyloid beta antibody measured by microdialysis
-
Part of Experimental Neurology, 2026
- DOI for Evaluating the impact of age and treatment on neuroinflammation-related proteins in mouse models of proteinopathies
- Download full text (pdf) of Evaluating the impact of age and treatment on neuroinflammation-related proteins in mouse models of proteinopathies
-
Part of Fluids and Barriers of the CNS, 2025
- DOI for High-affinity transferrin receptor binding improves brain delivery of bispecific antibodies at tracer dose
- Download full text (pdf) of High-affinity transferrin receptor binding improves brain delivery of bispecific antibodies at tracer dose
-
Part of Biomedicine and Pharmacotherapy, 2025
- DOI for Somatostatin therapy, neprilysin activation, and amyloid beta reduction: A novel approach for Alzheimer's treatment
- Download full text (pdf) of Somatostatin therapy, neprilysin activation, and amyloid beta reduction: A novel approach for Alzheimer's treatment
-
PET imaging of TREM2 in amyloid-beta induced neuroinflammation
Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 4320-4333, 2025
- DOI for PET imaging of TREM2 in amyloid-beta induced neuroinflammation
- Download full text (pdf) of PET imaging of TREM2 in amyloid-beta induced neuroinflammation
-
Part of Translational Neurodegeneration, 2025
- DOI for Pretargeted brain PET imaging reveals amyloid-β pathology using a TCO-modified antibody and a fluorine-18-labeled tetrazine
- Download full text (pdf) of Pretargeted brain PET imaging reveals amyloid-β pathology using a TCO-modified antibody and a fluorine-18-labeled tetrazine
-
Part of Acta neuropathologica communications, 2025
- DOI for Cryo-EM studies of amyloid-β fibrils from human and murine brains carrying the Uppsala APP mutation (Δ690-695)
- Download full text (pdf) of Cryo-EM studies of amyloid-β fibrils from human and murine brains carrying the Uppsala APP mutation (Δ690-695)
-
Bispecific brain-penetrant antibodies for treatment of Alzheimer's disease
Part of The Journal of Prevention of Alzheimer's Disease, 2025
- DOI for Bispecific brain-penetrant antibodies for treatment of Alzheimer's disease
- Download full text (pdf) of Bispecific brain-penetrant antibodies for treatment of Alzheimer's disease
-
Part of EJNMMI Radiopharmacy and Chemistry, 2025
- DOI for Brain-penetrating peptide and antibody radioligands for proof-of-concept PET imaging of fibrin in Alzheimer's disease
- Download full text (pdf) of Brain-penetrating peptide and antibody radioligands for proof-of-concept PET imaging of fibrin in Alzheimer's disease
-
Fluorine-18 ImmunoPET Imaging of Antibody Brain Kinetics and Amyloid-Beta Pathology
Part of ACS Pharmacology & Translational Science, p. 2804-2813, 2025
- DOI for Fluorine-18 ImmunoPET Imaging of Antibody Brain Kinetics and Amyloid-Beta Pathology
- Download full text (pdf) of Fluorine-18 ImmunoPET Imaging of Antibody Brain Kinetics and Amyloid-Beta Pathology
-
Part of EJNMMI Radiopharmacy and Chemistry, 2025
- DOI for Development of a toxin-selective immunotracer for in vivo detection of Clostridioides difficile infection by immunoPET
- Download full text (pdf) of Development of a toxin-selective immunotracer for in vivo detection of Clostridioides difficile infection by immunoPET
-
Part of Neurotherapeutics, 2025
- DOI for A brain-penetrant bispecific antibody lowers oligomeric alpha-synuclein and activates microglia in a mouse model of alpha-synuclein pathology
- Download full text (pdf) of A brain-penetrant bispecific antibody lowers oligomeric alpha-synuclein and activates microglia in a mouse model of alpha-synuclein pathology
-
Part of Analytical Chemistry, p. 1338-1346, 2025
- DOI for Comprehensive Approach for Sequential MALDI-MSI Analysis of Lipids, N-Glycans, and Peptides in Fresh-Frozen Rodent Brain Tissues
- Download full text (pdf) of Comprehensive Approach for Sequential MALDI-MSI Analysis of Lipids, N-Glycans, and Peptides in Fresh-Frozen Rodent Brain Tissues
-
The effects of dose, valency, and affinity on TfR-mediated brain delivery in vivo
Part of Fluids and Barriers of the CNS, 2025
- DOI for The effects of dose, valency, and affinity on TfR-mediated brain delivery in vivo
- Download full text (pdf) of The effects of dose, valency, and affinity on TfR-mediated brain delivery in vivo
-
Part of Journal of Biological Chemistry, 2025
- DOI for Dual-ligand fluorescence microscopy enables chronological and spatial histological assignment of distinct amyloid-β deposits
- Download full text (pdf) of Dual-ligand fluorescence microscopy enables chronological and spatial histological assignment of distinct amyloid-β deposits
-
Part of mAbs, 2024
- DOI for Reducing neonatal Fc receptor binding enhances clearance and brain-to-blood ratio of TfR-delivered bispecific amyloid-β antibody
- Download full text (pdf) of Reducing neonatal Fc receptor binding enhances clearance and brain-to-blood ratio of TfR-delivered bispecific amyloid-β antibody
-
Part of Analytical Biochemistry, 2024
- DOI for Comparing in vitro affinity measurements of antibodies to TfR1: Surface plasmon resonance versus on-cell affinity
- Download full text (pdf) of Comparing in vitro affinity measurements of antibodies to TfR1: Surface plasmon resonance versus on-cell affinity
-
Antibody engagement with amyloid‐beta does not inhibit [11C]PiB binding for PET imaging
Part of Journal of Neurochemistry, p. 2601-2610, 2024
- DOI for Antibody engagement with amyloid‐beta does not inhibit [11C]PiB binding for PET imaging
- Download full text (pdf) of Antibody engagement with amyloid‐beta does not inhibit [11C]PiB binding for PET imaging
-
Active CNS delivery of oxycodone in healthy and endotoxemic pigs
Part of Fluids and Barriers of the CNS, 2024
- DOI for Active CNS delivery of oxycodone in healthy and endotoxemic pigs
- Download full text (pdf) of Active CNS delivery of oxycodone in healthy and endotoxemic pigs
-
Part of mAbs, 2024
- DOI for Single domain antibody-scFv conjugate targeting amyloid β and TfR penetrates the blood–brain barrier and interacts with amyloid β
- Download full text (pdf) of Single domain antibody-scFv conjugate targeting amyloid β and TfR penetrates the blood–brain barrier and interacts with amyloid β
-
Indium-111 radiolabelling of a brain-penetrant Aβ antibody for SPECT imaging
Part of Upsala Journal of Medical Sciences, 2024
- DOI for Indium-111 radiolabelling of a brain-penetrant Aβ antibody for SPECT imaging
- Download full text (pdf) of Indium-111 radiolabelling of a brain-penetrant Aβ antibody for SPECT imaging
-
Synthesis and evaluation of fluorine-18 labelled tetrazines as pre-targeting imaging agents for PET
Part of EJNMMI Radiopharmacy and Chemistry, 2024
- DOI for Synthesis and evaluation of fluorine-18 labelled tetrazines as pre-targeting imaging agents for PET
- Download full text (pdf) of Synthesis and evaluation of fluorine-18 labelled tetrazines as pre-targeting imaging agents for PET
-
Part of Acta neuropathologica communications, 2024
- DOI for Altered amyloid-β structure markedly reduces gliosis in the brain of mice harboring the Uppsala APP deletion
- Download full text (pdf) of Altered amyloid-β structure markedly reduces gliosis in the brain of mice harboring the Uppsala APP deletion
-
Development of brain-penetrable antibody radioligands for in vivo PET imaging of amyloid-β and tau
Part of Frontiers in Nuclear Medicine, 2023
- DOI for Development of brain-penetrable antibody radioligands for in vivo PET imaging of amyloid-β and tau
- Download full text (pdf) of Development of brain-penetrable antibody radioligands for in vivo PET imaging of amyloid-β and tau
-
Synaptic density in aging mice measured by [18F]SynVesT-1 PET
Part of NeuroImage, 2023
- DOI for Synaptic density in aging mice measured by [18F]SynVesT-1 PET
- Download full text (pdf) of Synaptic density in aging mice measured by [18F]SynVesT-1 PET
-
Part of Nature Neuroscience, p. 2073-2080, 2023
- DOI for Cryo-EM of Aβ fibrils from mouse models find tg-APPArcSwe fibrils resemble those found in patients with sporadic Alzheimer's disease
- Download full text (pdf) of Cryo-EM of Aβ fibrils from mouse models find tg-APPArcSwe fibrils resemble those found in patients with sporadic Alzheimer's disease
-
Part of Alzheimer's Research & Therapy, 2023
- DOI for Long-term effects of immunotherapy with a brain penetrating Aβ antibody in a mouse model of Alzheimer's disease
- Download full text (pdf) of Long-term effects of immunotherapy with a brain penetrating Aβ antibody in a mouse model of Alzheimer's disease
-
Age, dose, and binding to TfR on blood cells influence brain delivery of a TfR-transported antibody
Part of Fluids and Barriers of the CNS, 2023
- DOI for Age, dose, and binding to TfR on blood cells influence brain delivery of a TfR-transported antibody
- Download full text (pdf) of Age, dose, and binding to TfR on blood cells influence brain delivery of a TfR-transported antibody
-
Pretargeted imaging beyond the blood-brain barrier
Part of RSC Medicinal Chemistry, p. 444-453, 2023
- DOI for Pretargeted imaging beyond the blood-brain barrier
- Download full text (pdf) of Pretargeted imaging beyond the blood-brain barrier
-
Part of Neurotherapeutics, p. 1588-1602, 2022
- DOI for A Brain-Targeting Bispecific-Multivalent Antibody Clears Soluble Amyloid-Beta Aggregates in Alzheimer's Disease Mice
- Download full text (pdf) of A Brain-Targeting Bispecific-Multivalent Antibody Clears Soluble Amyloid-Beta Aggregates in Alzheimer's Disease Mice
-
Part of Frontiers in Nuclear Medicine, 2022
- DOI for The Alzheimer's disease 5xFAD mouse model is best suited to investigate pretargeted imaging approaches beyond the blood-brain barrier
- Download full text (pdf) of The Alzheimer's disease 5xFAD mouse model is best suited to investigate pretargeted imaging approaches beyond the blood-brain barrier
-
Development of the First Tritiated Tetrazine: Facilitating Tritiation of Proteins
Part of ChemBioChem, 2022
- DOI for Development of the First Tritiated Tetrazine: Facilitating Tritiation of Proteins
- Download full text (pdf) of Development of the First Tritiated Tetrazine: Facilitating Tritiation of Proteins
-
Part of Fluids and Barriers of the CNS, 2022
- DOI for Brain pharmacokinetics of mono- and bispecific amyloid-beta antibodies in wild-type and Alzheimer's disease mice measured by high cut-off microdialysis
- Download full text (pdf) of Brain pharmacokinetics of mono- and bispecific amyloid-beta antibodies in wild-type and Alzheimer's disease mice measured by high cut-off microdialysis
-
Transferrin Receptor Binding BBB-Shuttle Facilitates Brain Delivery of Anti-A beta-Affibodies
Part of Pharmaceutical research, p. 1509-1521, 2022
- DOI for Transferrin Receptor Binding BBB-Shuttle Facilitates Brain Delivery of Anti-A beta-Affibodies
- Download full text (pdf) of Transferrin Receptor Binding BBB-Shuttle Facilitates Brain Delivery of Anti-A beta-Affibodies
-
Part of Pharmaceutics, 2022
- DOI for Reduction of alpha SYN Pathology in a Mouse Model of PD Using a Brain-Penetrating Bispecific Antibody
- Download full text (pdf) of Reduction of alpha SYN Pathology in a Mouse Model of PD Using a Brain-Penetrating Bispecific Antibody
-
In vivo imaging of alpha-synuclein with antibody-based PET
Part of Neuropharmacology, 2022
- DOI for In vivo imaging of alpha-synuclein with antibody-based PET
- Download full text (pdf) of In vivo imaging of alpha-synuclein with antibody-based PET
-
Part of Scientific Reports, 2022
- DOI for Introducing or removing heparan sulfate binding sites does not alter brain uptake of the blood-brain barrier shuttle scFv8D3
- Download full text (pdf) of Introducing or removing heparan sulfate binding sites does not alter brain uptake of the blood-brain barrier shuttle scFv8D3
-
Part of Translational Neurodegeneration, 2022
- DOI for ImmunoPET imaging of amyloid-beta in a rat model of Alzheimer's disease with a bispecific, brain-penetrating fusion protein
- Download full text (pdf) of ImmunoPET imaging of amyloid-beta in a rat model of Alzheimer's disease with a bispecific, brain-penetrating fusion protein
-
Part of Molecular Pharmaceutics, p. 4111-4122, 2022
- DOI for Functionalization of Radiolabeled Antibodies to Enhance Peripheral Clearance for High Contrast Brain Imaging
- Download full text (pdf) of Functionalization of Radiolabeled Antibodies to Enhance Peripheral Clearance for High Contrast Brain Imaging
-
Passive and receptor mediated brain delivery of an anti-GFAP nanobody
Part of Nuclear Medicine and Biology, p. 128-134, 2022
- DOI for Passive and receptor mediated brain delivery of an anti-GFAP nanobody
- Download full text (pdf) of Passive and receptor mediated brain delivery of an anti-GFAP nanobody
-
Part of Alzheimer's Research & Therapy, 2022
- DOI for Blood-brain barrier penetrating neprilysin degrades monomeric amyloid-beta in a mouse model of Alzheimer’s disease
- Download full text (pdf) of Blood-brain barrier penetrating neprilysin degrades monomeric amyloid-beta in a mouse model of Alzheimer’s disease
-
Pretargeted Imaging beyond the Blood-Brain Barrier-Utopia or Feasible?
Part of Pharmaceuticals, 2022
- DOI for Pretargeted Imaging beyond the Blood-Brain Barrier-Utopia or Feasible?
- Download full text (pdf) of Pretargeted Imaging beyond the Blood-Brain Barrier-Utopia or Feasible?
-
Increased CSF-decorin predicts brain pathological changes driven by Alzheimer's A beta amyloidosis
Part of Acta neuropathologica communications, 2022
- DOI for Increased CSF-decorin predicts brain pathological changes driven by Alzheimer's A beta amyloidosis
- Download full text (pdf) of Increased CSF-decorin predicts brain pathological changes driven by Alzheimer's A beta amyloidosis
-
Professor Margareta Hammarlund-Udenaes: a Modern and Visionary Mentor
Part of Pharmaceutical research, p. 1291-1296, 2022
-
Part of Journal of Nuclear Medicine, p. 302-309, 2022
- DOI for 11C-PiB and 124I-antibody PET provide differing estimates of brain amyloid-β after therapeutic intervention
- Download full text (pdf) of 11C-PiB and 124I-antibody PET provide differing estimates of brain amyloid-β after therapeutic intervention
-
Part of Theranostics, p. 789-804, 2021
- DOI for Enhanced neprilysin-mediated degradation of hippocampal A beta 42 with a somatostatin peptide that enters the brain
- Download full text (pdf) of Enhanced neprilysin-mediated degradation of hippocampal A beta 42 with a somatostatin peptide that enters the brain
-
Part of ACS Chemical Neuroscience, p. 2529-2541, 2021
- DOI for Wide-Ranging Effects on the Brain Proteome in a Transgenic Mouse Model of Alzheimer's Disease Following Treatment with a Brain-Targeting Somatostatin Peptide
- Download full text (pdf) of Wide-Ranging Effects on the Brain Proteome in a Transgenic Mouse Model of Alzheimer's Disease Following Treatment with a Brain-Targeting Somatostatin Peptide
-
Brain pharmacokinetics of two BBB penetrating bispecific antibodies of different size
Part of Fluids and Barriers of the CNS, 2021
- DOI for Brain pharmacokinetics of two BBB penetrating bispecific antibodies of different size
- Download full text (pdf) of Brain pharmacokinetics of two BBB penetrating bispecific antibodies of different size
-
Part of NeuroImage, 2021
- DOI for In vivo imaging of synaptic density with [C-11]UCB-J PET in two mouse models of neurodegenerative disease
- Download full text (pdf) of In vivo imaging of synaptic density with [C-11]UCB-J PET in two mouse models of neurodegenerative disease
-
Pinpointing Brain TREM2 Levels in Two Mouse Models of Alzheimer's Disease
Part of Molecular Imaging and Biology, p. 665-675, 2021
- DOI for Pinpointing Brain TREM2 Levels in Two Mouse Models of Alzheimer's Disease
- Download full text (pdf) of Pinpointing Brain TREM2 Levels in Two Mouse Models of Alzheimer's Disease
-
Fluorine-18-Labeled Antibody Ligands for PET Imaging of Amyloid-β in Brain
Part of ACS Chemical Neuroscience, p. 4460-4468, 2020
- DOI for Fluorine-18-Labeled Antibody Ligands for PET Imaging of Amyloid-β in Brain
- Download full text (pdf) of Fluorine-18-Labeled Antibody Ligands for PET Imaging of Amyloid-β in Brain
-
Blocking of efflux transporters in rats improves translational validation of brain radioligands
Part of EJNMMI Research, 2020
- DOI for Blocking of efflux transporters in rats improves translational validation of brain radioligands
- Download full text (pdf) of Blocking of efflux transporters in rats improves translational validation of brain radioligands
-
Part of Translational Neurodegeneration, 2020
- DOI for SPECT imaging of distribution and retention of a brain-penetrating bispecific amyloid-beta antibody in a mouse model of Alzheimer's disease
- Download full text (pdf) of SPECT imaging of distribution and retention of a brain-penetrating bispecific amyloid-beta antibody in a mouse model of Alzheimer's disease
-
Brain delivery of biologics using a cross-species reactive transferrin receptor 1 VNAR shuttle.
Part of The FASEB Journal, p. 13272-13283, 2020
- DOI for Brain delivery of biologics using a cross-species reactive transferrin receptor 1 VNAR shuttle.
- Download full text (pdf) of Brain delivery of biologics using a cross-species reactive transferrin receptor 1 VNAR shuttle.
-
Part of Journal of Neurochemistry, p. 602-616, 2020
-
Long-Term Effects of Traumatic Brain Injury in a Mouse Model of Alzheimer's Disease
Part of Journal of Alzheimer's Disease, p. 161-180, 2019
- DOI for Long-Term Effects of Traumatic Brain Injury in a Mouse Model of Alzheimer's Disease
- Download full text (pdf) of Long-Term Effects of Traumatic Brain Injury in a Mouse Model of Alzheimer's Disease
-
Part of Journal of Biological Chemistry, p. 6719-6732, 2019
- DOI for Pyroglutamation of amyloid-βx-42 (Aβx-42) followed by Aβ1–40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology
- Download full text (pdf) of Pyroglutamation of amyloid-βx-42 (Aβx-42) followed by Aβ1–40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology
-
High detection sensitivity with antibody-based PET radioligand for amyloid beta in brain
Part of NeuroImage, p. 881-888, 2019
-
Part of EJNMMI Radiopharmacy and Chemistry, 2018
- DOI for Synthesis and preliminary preclinical evaluation of fluorine-18 labelled isatin-4-(4-methoxyphenyl)-3-thiosemicarbazone ([18F]4FIMPTC) as a novel PET tracer of P-glycoprotein expression
- Download full text (pdf) of Synthesis and preliminary preclinical evaluation of fluorine-18 labelled isatin-4-(4-methoxyphenyl)-3-thiosemicarbazone ([18F]4FIMPTC) as a novel PET tracer of P-glycoprotein expression
-
Part of Neuropharmacology, p. 1-9, 2018
- DOI for Blood-Brain Barrier Integrity in a Mouse Model of Alzheimer’s Disease With or Without Acute 3D6 Immunotherapy
- Download full text (pdf) of Blood-Brain Barrier Integrity in a Mouse Model of Alzheimer’s Disease With or Without Acute 3D6 Immunotherapy
-
Part of Neuropharmacology, p. 482-491, 2018
- DOI for Intact blood-brain barrier transport of small molecular drugs in animal models of amyloid beta and alpha-synuclein pathology
- Download full text (pdf) of Intact blood-brain barrier transport of small molecular drugs in animal models of amyloid beta and alpha-synuclein pathology
-
Part of Journal of Nuclear Medicine, p. 1885-1891, 2018
- DOI for Antibody-Based In Vivo PET Imaging Detects Amyloid-beta Reduction in Alzheimer Transgenic Mice After BACE-1 Inhibition
- Download full text (pdf) of Antibody-Based In Vivo PET Imaging Detects Amyloid-beta Reduction in Alzheimer Transgenic Mice After BACE-1 Inhibition
-
Part of Alzheimer's Research & Therapy, 2018
- DOI for Efficient clearence of A beta protofibrils in A beta PP-transgenic mice treated with a brain-penetrating bifunctional antibody
- Download full text (pdf) of Efficient clearence of A beta protofibrils in A beta PP-transgenic mice treated with a brain-penetrating bifunctional antibody
-
[F-18]Tetrazine-trans-cyclooctene mediated labelling of antibodies for PET imaging of amyloid-beta
Part of European Journal of Nuclear Medicine and Molecular Imaging, 2018
-
Part of European Journal of Pharmaceutical Sciences, p. 61-70, 2018
- DOI for P-glycoprotein protein expression versus functionality at the blood-brain barrier using immunohistochemistry, microdialysis and mathematical modeling
- Download full text (pdf) of P-glycoprotein protein expression versus functionality at the blood-brain barrier using immunohistochemistry, microdialysis and mathematical modeling
-
Astroglial Responses to Amyloid-Beta Progression in a Mouse Model of Alzheimer's Disease
Part of Molecular Imaging and Biology, p. 605-614, 2018
- DOI for Astroglial Responses to Amyloid-Beta Progression in a Mouse Model of Alzheimer's Disease
- Download full text (pdf) of Astroglial Responses to Amyloid-Beta Progression in a Mouse Model of Alzheimer's Disease
-
Part of Biological Procedures Online, 2017
- DOI for Efficient and inexpensive transient expression of multispecific multivalent antibodies in Expi293 cells
- Download full text (pdf) of Efficient and inexpensive transient expression of multispecific multivalent antibodies in Expi293 cells
-
Part of Journal of Cerebral Blood Flow and Metabolism, p. 415-416, 2017
-
Bivalent Brain Shuttle Increases Antibody Uptake by Monovalent Binding to the Transferrin Receptor
Part of Theranostics, p. 308-318, 2017
- DOI for Bivalent Brain Shuttle Increases Antibody Uptake by Monovalent Binding to the Transferrin Receptor
- Download full text (pdf) of Bivalent Brain Shuttle Increases Antibody Uptake by Monovalent Binding to the Transferrin Receptor
-
Part of ACS Chemical Neuroscience, p. 347-355, 2017
- DOI for Delineating Amyloid Plaque Associated Neuronal Sphingolipids in Transgenic Alzheimer's Disease Mice (tgArcSwe) Using MALDI Imaging Mass Spectrometry
- Download full text (pdf) of Delineating Amyloid Plaque Associated Neuronal Sphingolipids in Transgenic Alzheimer's Disease Mice (tgArcSwe) Using MALDI Imaging Mass Spectrometry
-
Part of Scientific Reports, 2017
- DOI for Pharmacokinetics, biodistribution and brain retention of a bispecific antibody-based PET radioligand for imaging of amyloid-beta
- Download full text (pdf) of Pharmacokinetics, biodistribution and brain retention of a bispecific antibody-based PET radioligand for imaging of amyloid-beta
-
Part of NeuroImage, p. 177-186, 2017
-
Cationization increases brain distribution of an amyloid-beta protofibril selective F(ab')2 fragment
Part of Biochemical and Biophysical Research Communications - BBRC, p. 120-125, 2017
- DOI for Cationization increases brain distribution of an amyloid-beta protofibril selective F(ab')2 fragment
- Download full text (pdf) of Cationization increases brain distribution of an amyloid-beta protofibril selective F(ab')2 fragment
-
Part of Neuropharmacology, p. 293-300, 2017
-
Antibody-based PET radioligands for imaging of amyloid-beta protofibrils
Part of Journal of Cerebral Blood Flow and Metabolism, p. 84-84, 2017
-
Part of NeuroImage, p. 55-63, 2017
- DOI for A bispecific Tribody PET radioligand for visualization of amyloid-beta protofibrils - a new concept for neuroimaging
- Download full text (pdf) of A bispecific Tribody PET radioligand for visualization of amyloid-beta protofibrils - a new concept for neuroimaging
-
Antibody-based PET imaging of amyloid beta in mouse models of Alzheimer's disease
Part of Nature Communications, 2016
- DOI for Antibody-based PET imaging of amyloid beta in mouse models of Alzheimer's disease
- Download full text (pdf) of Antibody-based PET imaging of amyloid beta in mouse models of Alzheimer's disease
-
Part of Journal of Neurochemistry, p. 469-478, 2016
-
Part of Neuropharmacology, p. 104-112, 2014
-
Part of Epilepsia, p. 32-32, 2014
-
Mechanism-Based Evaluation of Codeine Toxicity in Children
Part of Clinical Pharmacology and Therapeutics, 2014
-
Part of Journal of Alzheimer's Disease, p. 29-40, 2013
-
Part of Nuclear Medicine and Biology, p. 764-775, 2013
-
Part of AAPS Journal, p. 87-96, 2012
-
Part of EJNMMI Research, p. 12, 2012
-
Part of EJNMMI Research, p. 36, 2012
-
Part of EJNMMI Research, 2012
- DOI for Pharmacokinetic modeling of P-glycoprotein function at the rat and human blood--brain barriers studied with (R)-[11C]verapamil positron emission tomography.
- Download full text (pdf) of Pharmacokinetic modeling of P-glycoprotein function at the rat and human blood--brain barriers studied with (R)-[11C]verapamil positron emission tomography.
-
Part of Journal of Nuclear Medicine, p. 1974-1983, 2012
-
Synthesis and preclinical evaluation of [11C]D617, a metabolite of (R)-[11C]verapamil.
Part of Nuclear Medicine and Biology, p. 530-9, 2012
-
Part of NeuroImage, p. 928-37, 2011
-
Part of BMC medical imaging, p. 1, 2011
-
Part of Drug Metabolism And Disposition, p. 635-643, 2009
-
Part of BMC Medical Physics, 2008
-
Pharmacokinetics of P-glycoprotein inhibition in the rat blood-brain barrier
Part of Journal of Pharmaceutical Sciences, p. 5386-5400, 2008
-
Part of BMC Medical Imaging, p. 6, 2007
-
Part of Drug Metabolism Letters, p. 189-194, 2007
-
Part of Synapse, p. 440-449, 2007
-
Part of NeuroImage, p. 1134-1141, 2006
-
Pharmacokinetic consequences of active drug efflux at the blood-brain barrier
Part of Pharmaceutical research, p. 705-717, 2006
-
Blood-brain barrier penetration of zolmitriptan--modelling of positron emission tomography data
Part of Journal of Pharmacokinetics and Pharmacodynamics, p. 75-91, 2006
-
Part of European Journal of Clinical Pharmacology, p. 839-848, 2006
Articles, review/survey
-
Advances in the development of new biomarkers for Alzheimer's disease
Part of Translational Neurodegeneration, 2022
- DOI for Advances in the development of new biomarkers for Alzheimer's disease
- Download full text (pdf) of Advances in the development of new biomarkers for Alzheimer's disease
-
PET Imaging in Preclinical Anti-Aβ Drug Development
Part of Pharmaceutical research, p. 1481-1496, 2022
- DOI for PET Imaging in Preclinical Anti-Aβ Drug Development
- Download full text (pdf) of PET Imaging in Preclinical Anti-Aβ Drug Development
-
Engineered antibodies: new possibilities for brain PET?
Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 2848-2858, 2019
- DOI for Engineered antibodies: new possibilities for brain PET?
- Download full text (pdf) of Engineered antibodies: new possibilities for brain PET?
-
Advances in PET Imaging of P-Glycoprotein Function at the Blood-Brain Barrier.
Part of ACS Chemical Neuroscience, p. 225-237, 2013
-
Using PET Studies of P-gp Function to Elucidate Mechanisms Underlying the Disposition of Drugs
Part of Current Topics in Medicinal Chemistry, p. 1799-1809, 2010
-
On the rate and extent of drug delivery to the brain
Part of Pharmaceutical research, p. 1737-1750, 2008
Chapters in book
-
In Vivo Studies of Drug BBB Transport: Translational Challenges and the Role of Brain Imaging
Part of Handbook of Experimental Pharmacology, p. 223-244, Springer, 2022
-
Brain Distribution of Drugs: Pharmacokinetic Considerations
Part of Handbook of Experimental Pharmacology, p. 121-150, Springer, 2022
Comprehensive doctoral thesis
Conference papers
Manuscripts (preprints)
-
-
The Uppsala APP mutation promotes wildtype Aβ aggregation and deposition in vivo
-
-
Single domain antibody conjugated to Aβ-binding scFv penetrates BBB via TfR to interact with Aβ
-
Synaptic density in aging mice measured by [18F]SynVesT-1 PET
-
[11C]PiB binding after treatment with an amyloid-beta antibody
-
-
-
-
Evaluation of valency effects on TfR-mediated brain delivery in vivo